2022-11-14T14:21:04-06:00 2021-12-31 521853933 JM&M 10500 LITTLE PATUXENT PARKWAY SUITE 770 COLUMBIA MD 21044 990 2021-01-01 222432063 INTERNATIONAL SOCIETY FOR THE STUDY OF XENOBIOTICS INTE 2023671160 2001 K STREET NW 3RD FLOOR NORTH WASHINGTON DC 20006 ZOE FULLER EXECUTIVE DIRECTOR 2023671160 2022-11-11 1 ZOE FULLER 999009999 P01608821 4108840220 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z ZOE FULLER 2001 K STREET NW 3RD FLOOR NORTH WASHINGTON DC 20006 1066514 0 X WWW.ISSX.ORG X 1981 NJ ISSX IS AN INTERNATIONAL ASSOCIATION OF SCIENTISTS THAT PROMOTES THE UNDERSTANDING OF THE INTERACTIONS OF MEDICINES AND CHEMICALS WITH LIVING SYSTEMS. 10 10 0 76 4257 0 22788 10445 110391 494630 86863 39229 10000 2617 230042 546921 4000 2908 0 0 0 0 0 0 61354 492342 465612 496342 468520 -266300 78401 1248500 1335115 71519 38321 1176981 1296794 ISSX IS AN INTERNATIONAL ASSOCIATION OF SCIENTISTS THAT PROMOTES THE UNDERSTANDING OF THE INTERACTIONS OF MEDICINES AND CHEMICALS WITH LIVING SYSTEMS. 0 0 227263 1699 355414 SCIENTIFIC MEETINGS - ISSX ORGANIZES DOMESTIC AND INTERNATIONAL SCIENTIFIC MEETINGS TO BRING TOGETHER RESEARCHERS TO ADVANCE THEIR KNOWLEDGE ON THE INTERPLAY OF LIVING SYSTEMS WITH MEDICINES AND CHEMICALS. DUE TO COVID-19, IN THE INTEREST OF THE HEALTH AND SAFETY OF THE PARTICIPANTS AS WELL AS STATE AND LOCAL MANDATES, ISSX CANCELLED ALL IN-PERSON MEETINGS DURING 2020. DURING THE YEAR ENDED DECEMBER 31, 2021, ISSX HELD IT'S SCIENTIFIC MEETING VIRTUALLY. 19927 1209 134959 OTHER PROGRAMS - ISSX AWARD PROGRAMS RECOGNIZE SCIENTIFIC AND SERVICE ACHIEVEMENTS THROUGH THE INTERNATIONAL DISTINGUISHED SCIENTIFIC ACHIEVEMENT AND DISTINGUISHED SERVICE AWARDS, THE REGIONAL SCIENTIFIC AND NEW INVESTIGATOR AWARDS, AND OTHER ACTIVITIES TO PROMOTE RESEARCH AND THE DISSEMINATION OF INFORMATION CONCERNING THE INTERPLAY OF LIVING SYSTEMS WITH MEDICINES AND CHEMICALS. 1612 LEADERSHIP - ISSX FOSTERS AND ENCOURAGES THE EXCHANGE OF INFORMATION AMONGST RESEARCHERS ON INTERDISCIPLINARY AND INNOVATIVE SCIENCE RELATED TO THE DISPOSITION METABOLISM AND BIOLOGICAL EFFECTS OF DRUGS AND OTHER XENOBIOTICS. 248802 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 X 10 10 0 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X SMITHBUCKLIN CORPORATION 2023671160 2001 K STREET NW 3RD FLOOR NORTH WASHINGTON DC 20006 X ANN DALY PRESIDENT 4.00 X X 0 0 0 SCOTT OBACH PRESIDENT-ELECT/SECRETARY 4.00 X X 0 0 0 ERIN SCHUETZ TREASURER 1.00 X X 0 0 0 SANDY PANG TREASURER-ELECT 1.00 X X 0 0 0 SIMONE SCHADT COUNCIL MEMBER 1.00 X 0 0 0 KOUICHI YOSHINARI COUNCIL MEMBER 1.00 X 0 0 0 KIYOMI ITO COUNCIL MEMBER 1.00 X 0 0 0 NINA ISOHERRANEN COUNCIL MEMBER 1.00 X 0 0 0 JASHVANT UNADKAT COUNCIL MEMBER 1.00 X 0 0 0 UWE FUHR COUNCIL MEMBER 1.00 X 0 0 0 ZOE FULLER EXECUTIVE DIRECTOR 20.00 X 0 0 0 0 0 0 0 0 0 0 SMITHBUCKLIN CORPORATION 2001 K STREET NW 3RD FLOOR NORTH WASHINGTON DC 20006 MANAGEMENT/ED COMPENSATION 316113 1 10445 10445 NO. AMERICAN MEETING 900099 234584 234584 WORKSHOP REVENUE 900099 133022 133022 MEMBERSHIP DUES 900099 120830 120830 ADVERTISING INCOME 541800 4257 4257 WEBINAR REVENUE 900099 1937 1937 494630 39109 39109 519713 519593 120 120 120 MISC. REFUNDS 900099 2617 2617 2617 546921 490373 4257 41846 2908 2908 337565 180722 101069 55774 9325 9325 8684 8684 5100 5100 32153 1243 30910 7537 1957 5580 56872 56872 5655 5655 MISCELLANEOUS 2304 2304 STORAGE 417 417 468520 248802 158364 61354 279548 346262 11561 121 40617 916774 988732 1248500 1335115 16041 6501 55478 31820 71519 38321 X 713117 812243 463864 484551 1176981 1296794 1248500 1335115 78401 41412 0 X X 0 1 X 1 0 X 34483 655 20635 22788 10445 89006 1104869 676416 819034 106669 490373 3197361 1139352 677071 839669 129457 500818 3286367 0 6163 10000 18275 34438 6163 10000 18275 34438 3251929 40554 42574 43887 44272 39109 210396 40554 42574 43887 44272 39109 210396 2042 1243 3285 315 2531 117 10000 2617 15580 1182263 723419 883673 183729 542544 3515628 0.92500 0.93120 0.05980 0.05920 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: JOURNALS - 2017 AMOUNT: $ 315. MISCELLANEOUS REFUNDS - 2018 AMOUNT: $ 2,531. 2019 AMOUNT: $ 117. 2020 AMOUNT: $ 10,000. 2021 AMOUNT: $ 2,617. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 124173 6110 130283 116573 8780 1180 124173 102319 14254 116573 110690 86 -6199 2258 102319 100838 12374 2522 110690 0.30700 0.69300 0 0 0 X 579649 41412 41412 538237 8684 8684 546921 459836 0 459836 8684 8684 468520 PART V, LINE 4: THE ORGANIZATION WILL USE THE ENDOWMENT FUNDS TO SUPPORT THE NEW INVESTIGATOR (GILETTE) AWARD. PART X, LINE 2: ISSX BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE FINANCIAL STATEMENTS OR THAT WOULD HAVE AN EFFECT ON ITS TAX-EXEMPT STATUS. THERE ARE NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES THAT NEED TO BE RECORDED. FORM 990, PART VI, SECTION A, LINE 3 ISSX HAS AN AGREEMENT WITH SMITHBUCKLIN CORPORATION TO MANAGE ITS OPERATIONS. PER THE AGREEMENT, SMITHBUCKLIN, INC. PROVIDES EXECUTIVE MANAGEMENT SERVICES TOTALING $70,000, MEMBERSHIPS AND OPERATIONS, EVENT SERVICES, SITE SELECTION AND CONTRACTING SERVICES, FINANCIAL MANAGEMENT AND ACCOUNTING SERVICES, SALES SERVICES, FULFILLMENT SERVICES, AND PROMOTIONAL PRODUCTS AND SUPPORT. SMITHBUCKLIN'S PERFORMANCE UNDER THIS AGREEMENT IS MONITORED BY THE BOARD OF ISSX. FORM 990, PART VI, SECTION A, LINE 6 ISSX IS A MEMBERSHIP ORGANIZATION. ANYONE ENGAGED IN RESEARCH IN XENOBIOTICS, OR IN THE ADMINISTRATION AND/OR REGULATIONS OF SUCH RESEARCH, OR ANYONE WHO EXPRESSES A SCIENTIFIC INTEREST IN THE FIELD WILL BE ELIGIBLE FOR MEMBERSHIP. MEMBERSHIP CATEGORIES ARE SET FORTH IN THE BY-LAWS. FORM 990, PART VI, SECTION A, LINE 7A THE ORGANIZATION'S MEMBERS HAVE THE POWER TO ELECT COUNCIL MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE EXECUTIVE DIRECTOR REVIEWS AND SIGNS THE FINAL FORM 990 AND FILES IT WITH THE IRS. THE EXECUTIVE DIRECTOR SENDS THE FORM 990 TO THE ENTIRE BOARD BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE COUNCIL MEMBERS WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. THE REMAINING COUNCIL MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE COUNCIL MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS NOT CHANGED ITS AUDIT OVERSIGHT PROCESS OR SELECTION PROCESS OF AN INDEPENDENT ACCOUNTANT DURING THE TAX YEAR.